| Literature DB >> 8373900 |
B Hennemann1, K J Bross, A Reichle, R Andreesen.
Abstract
Hydroxyurea is increasingly being used to control myeloproliferative disorders, in part because of its relative lack of side effects. We present a case of life-threatening alveolitis in a patient treated with hydroxyurea for myeloproliferative syndrome. Absence of exposure to other drugs and the clinical course suggest that the alveolitis was induced by hydroxyurea.Entities:
Mesh：
Substances：
Year: 1993 PMID： 8373900 DOI： 10.1007/bf01701737
Source DB: PubMed Journal: Ann Hematol ISSN： 0939-5555 Impact factor: 3.673